Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Euro Surveill ; 28(11)2023 03.
Article in English | MEDLINE | ID: covidwho-2288582

ABSTRACT

With COVID-19 public health control measures downgraded in China in January 2023, reported COVID-19 case numbers may underestimate the true numbers after the SARS-CoV-2 Omicron wave. Using a multiplier model based on our influenza surveillance system, we estimated that the overall incidence of SARS-CoV-2 infections was 392/100,000 population in Beijing during the 5 weeks following policy adjustment. No notable change occurred after the Spring Festival in early February. The multiplier model provides an opportunity for assessing the actual COVID-19 situation.


Subject(s)
COVID-19 , Influenza, Human , Humans , Beijing/epidemiology , SARS-CoV-2 , Influenza, Human/diagnosis , Influenza, Human/epidemiology , China/epidemiology
2.
J Epidemiol Community Health ; 75(1): 84-87, 2021 01.
Article in English | MEDLINE | ID: covidwho-733144

ABSTRACT

BACKGROUND: The presymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented in limited clusters, and it is predicted through modelling. However, there is a lack of evidence from observations with a large sample size. METHODS: We used data from meticulous contact tracing of people exposed to cases of SARS-CoV-2 to estimate the proportion of cases that result from the presymptomatic transmission of the virus in Beijing during January 2020 and February 2020. RESULTS: The results showed that presymptomatic transmission occurred in at least 15% of 100 secondary COVID-19 cases. The earliest presymptomatic contact event occurred 5 days prior to the index case's onset of symptoms, and this occurred in two clusters. CONCLUSIONS: The finding suggested that the contact tracing period should be earlier and highlighted the importance of preventing transmission opportunities well before the onset of symptoms.


Subject(s)
Asymptomatic Infections/epidemiology , COVID-19/transmission , Carrier State/virology , Disease Outbreaks , SARS-CoV-2/isolation & purification , Adult , Asymptomatic Diseases , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19 Nucleic Acid Testing , Carrier State/epidemiology , China/epidemiology , Contact Tracing , Female , Humans , Male , Middle Aged , SARS-CoV-2/genetics
SELECTION OF CITATIONS
SEARCH DETAIL